Dextromethorphan/quinidine (AVP-923) for treatment of agitation in patients with Alzheimer’s disease: Analysis of week 10 results for patients treated only with AVP-923 versus patients receiving only placebo (NCT01584440)

Autor: Cummings, Jeffrey L., Lyketsos, Constantine, Peskind, Elaine R., Porsteinsson, Anton P., Mintzer, Jacobo E., Scharre, Douglas W., De La Gándara, José E., Agronin, Marc, Nguyen, Uyen, Shin, Paul, Tariot, Pierre N., Siffert, Joao
Zdroj: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2015 11(7) Supplement:P291-P292
Databáze: ScienceDirect